x

Search for a diagnostic test

* (*) mandatory field

346 Result(s)

Filter by

Speciality(ies)/objective(s)

Technique(s)

Purpose(s)

Quality management

Country(ies)

Reset
Sort by

Caption : Accreditation =Accreditation
;

GERMANY

Nordrhein-Westfalen
MÖNCHENGLADBACH

Accreditation
Biochemical diagnosis of congenital plasminogen activator inhibitor type 1 deficiency
Medizinische Versorgungszentrum Dr.Stein + Kollegen
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Biochemical genetics
Objective(s) : Analyte / Enzyme assay

BELGIUM

ANTWERPEN
ANTWERPEN-EDEGEM

Accreditation
Molecular diagnosis of APC resistance due to Factor V Leiden (F5 gene)
University Hospital of Antwerp - UZA- Centrum Medische Genetica - CMG
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

UNITED KINGDOM

Lanarkshire
GLASGOW

Accreditation
Molecular diagnosis of hyperprothrombinemia (Prothrombin 20210A mutation)
Southern General Hospital
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

AUSTRIA

OBERÖSTERREICH
LINZ

Accreditation
Molecular diagnosis of non rare thrombophilia (F5: Leiden mutation (G1691A); F2: G20210A; MTHFR: C677T and A1298C)
Krankenhaus der Barmherzigen Schwestern Linz
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

UNITED KINGDOM

Wiltshire
SALISBURY

Accreditation
Molecular diagnosis of Factor V Deficiency - Leiden (F5: specific mutation analysis)
Salisbury District Hospital
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

UNITED KINGDOM

Wiltshire
SALISBURY

Accreditation
Molecular diagnosis of Hyperprothrombinemia (Prothrombin 20210A mutation)
Salisbury District Hospital
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

FRANCE

ILE-DE-FRANCE
IVRY SUR SEINE

Accreditation
Molecular diagnosis of MTHFR thermolabile variant (C677T mutation)
Biomnis
Purpose(s) : Post-natal diagnosis, Pre-symptomatic diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technical procedure(s) : PCR based techniques

UNITED KINGDOM

Greater London
HARROW

Accreditation
Molecular diagnosis of hyperprothrombinemia (Prothrombin 20210A, F2 gene)
North West London Hospitals NHS - Northwick Park & St Marks Hospital
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Rheinland-Pfalz
INGELHEIM AM RHEIN

Accreditation
Molecular diagnosis of MTHFR gene variant C677T
Bioscientia Institut für Medizinische Diagnostik GmbH
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Rheinland-Pfalz
INGELHEIM AM RHEIN

Accreditation
Molecular diagnosis of congential plasminogen activator inhibitor type 1 deficiency
Bioscientia Institut für Medizinische Diagnostik GmbH
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technical procedure(s) : Sanger sequencing

GERMANY

Nordrhein-Westfalen
KÖLN

Accreditation
Molecular diagnosis of MTHFR gene variant C677T
Praxisgemeinschaft für Laboratoriumsmedizin und Humangenetik
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Nordrhein-Westfalen
KÖLN

Accreditation
Molecular diagnosis of thrombophilia (4G/5G polymorphism in the promoter of the PAI1 gene)
Praxisgemeinschaft für Laboratoriumsmedizin und Humangenetik
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Bayern
MÜNCHEN

Accreditation
Molecular diagnosis of MTHFR gene variants C677T and C677T
Medizinisches Versorgungszentrum Humane Genetik
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Bayern
NEU-ULM

Accreditation
Risk calculation on molecular basis for thrombophilia (F2 gene: G20210A mutation)
Paxis und Labor Dr. med Karl Mehnert
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Bayern
NEU-ULM

Accreditation
Molecular diagnosis of factor V Leiden mutation
Paxis und Labor Dr. med Karl Mehnert
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Nordrhein-Westfalen
DORTMUND

Accreditation
Molecular diagnosis of factor V Leiden mutation
Medizinisches Versorgungszentrum (MVZ) Dr. Eberhard und Partner
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Nordrhein-Westfalen
DORTMUND

Accreditation
Risk calculation on molecular basis for thrombophilia (F2 gene: G20210A mutation)
Medizinisches Versorgungszentrum (MVZ) Dr. Eberhard und Partner
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Nordrhein-Westfalen
DORTMUND

Accreditation
Molecular diagnosis of MTHFR gene variant C677T, A1298C
Medizinisches Versorgungszentrum (MVZ) Dr. Eberhard und Partner
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

UNITED KINGDOM

Grampian
ABERDEEN

Accreditation
Molecular diagnosis of Factor V Deficiency (Leiden)
Aberdeen Royal Infirmary, Polwarth Building
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

UNITED KINGDOM

Grampian
ABERDEEN

Accreditation
Molecular diagnosis of hyperprothrombinemia (Prothrombin 20210A mutation)
Aberdeen Royal Infirmary, Polwarth Building
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

UNITED KINGDOM

Greater London
LONDON

Accreditation
Molecular diagnosis of Factor V deficiency (Leiden plus complete F5 gene)
St Thomas' Hospital
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

UNITED KINGDOM

Greater London
LONDON

Accreditation
Molecular diagnosis of Methylenetetrahydrofolate Reductase Deficiency (MTHFR), thermolabile variant (C677T)
St Thomas' Hospital
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

UNITED KINGDOM

Greater London
LONDON

Accreditation
Molecular diagnosis of Congenital Factor II deficiency (20210A plus complete Prothrombin gene)
St Thomas' Hospital
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

SPAIN

Cataluña
BARCELONA

Accreditation
Molecular diagnosis of predisposition to thrombophilia. F5 gene.
Laboratorio de Análisis Dr. Echevarne
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

GERMANY

Bayern
MARTINSRIED

Accreditation
Molecular diagnosis of factor V Leiden mutation
Zentrum für Humangenetik und Laboratoriumsdiagnostik (MVZ)
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Bayern
MARTINSRIED

Accreditation
Risk calculation on molecular basis for thrombophilia (F2 gene: G20210A mutation)
Zentrum für Humangenetik und Laboratoriumsdiagnostik (MVZ)
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Bayern
MÜNCHEN

Accreditation
Molecular diagnosis of factor V Leiden mutation
Medizinisches Versorgungszentrum Humane Genetik
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

AUSTRIA

TIROL
INNSBRUCK

Accreditation
Molecular diagnosis of Factor V Leiden mutation
Medizinische Universität Innsbruck
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

BELGIUM

HAINAUT
GOSSELIES

Accreditation
Molecular diagnosis of non-rare thrombophilia (Factor 2 20210G>A variant)
Institut de Pathologie et de Génétique - Gosselies
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Niedersachsen
GÖTTINGEN

Accreditation
Molecular diagnosis of MTHFR gene variants C677T and A1298C
Institut für Humangenetik der Universität Göttingen
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : Sanger sequencing

GERMANY

Rheinland-Pfalz
MAINZ

Accreditation
Risk calculation on molecular basis for thrombophilia (F2 gene: G20210A mutation)
Institut für Klinische Genetik Mainz
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Rheinland-Pfalz
MAINZ

Accreditation
Molecular diagnosis of factor V Leiden mutation
Institut für Klinische Genetik Mainz
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Rheinland-Pfalz
MAINZ

Accreditation
Molecular diagnosis of MTHFR gene variant C677T
Institut für Klinische Genetik Mainz
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Nordrhein-Westfalen
DORTMUND

Accreditation
Molecular diagnosis of thrombophilia (4G/5G polymorphism in the promoter of the SERPINE1 gene)
Medizinisches Versorgungszentrum (MVZ) Dr. Eberhard und Partner
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Sachsen
WEIßWASSER

Accreditation
Molecular diagnosis of factor V deficiency and resistance to activated protein C (F5 gene: fragment analysis and sequencing of selective regions)
Praxis Dr. Mato Nagel
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technical procedure(s) : Sanger sequencing

GERMANY

Sachsen
DRESDEN

Accreditation
Molecular diagnosis of thrombophilia (F5: factor V Leiden mutation, factor V Cambridge mutation, and others)
Mitteldeutscher Praxisverbund Humangenetik
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Nordrhein-Westfalen
MÖNCHENGLADBACH

Accreditation
Molecular diagnosis of factor V Leiden mutation
Medizinische Versorgungszentrum Dr.Stein + Kollegen
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Bayern
MÜNCHEN

Accreditation
Molecular diagnosis of factor V Leiden mutation (QF-PCR)
Pränatalmedizin München
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Technical procedure(s) : PCR based techniques

GERMANY

Bayern
MÜNCHEN

Accreditation
Molecular diagnosis of factor V Leiden mutation
Medizinisch Genetisches Zentrum München
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : Sanger sequencing

GERMANY

Nordrhein-Westfalen
KÖLN

Accreditation
Molecular diagnosis of factor V Leiden mutation
Praxisgemeinschaft für Laboratoriumsmedizin und Humangenetik
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Schleswig-Holstein
KIEL

Accreditation
Molecular diagnosis of factor V Leiden mutation
Universitätsklinikum Schleswig-Holstein - Campus Kiel
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : Sanger sequencing

GERMANY

Rheinland-Pfalz
INGELHEIM AM RHEIN

Accreditation
Molecular diagnosis of factor V Leiden mutation
Bioscientia Institut für Medizinische Diagnostik GmbH
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Nordrhein-Westfalen
MÖNCHENGLADBACH

Accreditation
Risk calculation on molecular basis for thrombophilia (F2 gene: G20210A mutation)
Medizinische Versorgungszentrum Dr.Stein + Kollegen
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Rheinland-Pfalz
INGELHEIM AM RHEIN

Accreditation
Risk calculation on molecular basis for thrombophilia (F2 gene: G20210A mutation)
Bioscientia Institut für Medizinische Diagnostik GmbH
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Bayern
MARTINSRIED

Accreditation
Molecular diagnosis of thrombophilia (4G/5G polymorphism in the promoter of the PAI1 gene)
Zentrum für Humangenetik und Laboratoriumsdiagnostik (MVZ)
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

FRANCE

ILE-DE-FRANCE
SAINT-OUEN-L'AUMÔNE

Accreditation
Diagnostic of susceptibility to non rare thrombophilia (mutations R506Q, G20210A, C677T variant)
Laboratoire Cerba
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

GERMANY

Mecklenburg-Vorpommern
ROSTOCK

Accreditation
Molecular diagnosis of factor V Leiden mutation
Centogene AG
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Mecklenburg-Vorpommern
ROSTOCK

Accreditation
Risk calculation on molecular basis for thrombophilia (F2 gene: G20210A mutation)
Centogene AG
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Bayern
MÜNCHEN

Accreditation
Molecular diagnosis of thrombophilia (4G/5G polymorphism in the promoter of the PAI1 gene)
Medizinisches Versorgungszentrum Humane Genetik
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

UNITED KINGDOM

Avon
BRISTOL

Accreditation
Molecular diagnosis of resistance to activated protein C - Factor V Leiden (F5 gene, G1691A mutation)
Southmead Hospital
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Nordrhein-Westfalen
MÖNCHENGLADBACH

Accreditation
Molecular diagnosis of MTHFR gene variant C677T
Medizinische Versorgungszentrum Dr.Stein + Kollegen
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Schleswig-Holstein
KIEL

Accreditation
Risk calculation on molecular basis for thrombophilia (F2 gene: G20210A mutation)
Universitätsklinikum Schleswig-Holstein - Campus Kiel
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : Sanger sequencing

FINLAND

Finland
HELSINKI

Accreditation
Molecular diagnosis of hyperprothrombinemia (F2 gene: G20210A mutation)
Yhtyneet Medix Laboratoriot
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

FINLAND

Finland
HELSINKI

Accreditation
Molecular diagnosis of factor V deficiency (F5 gene: G1691A mutation)
Yhtyneet Medix Laboratoriot
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Niedersachsen
HANNOVER

Accreditation
Molecular diagnosis of MTHFR gene variant C677T
Medizinische Hochschule Hannover
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Sachsen
LEIPZIG

Accreditation
Risk calculation on molecular basis for thrombophilia (F2 gene: G20210A mutation)
MVZ Labor Dr. Reising-Ackermann und Kollegen
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Sachsen
LEIPZIG

Accreditation
Molecular diagnosis of thrombophilia (F5: factor V Leiden mutation, factor V Cambridge mutation, H1299R)
MVZ Labor Dr. Reising-Ackermann und Kollegen
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Sachsen
LEIPZIG

Accreditation
Molecular diagnosis of thrombophilia (4G/5G polymorphism in the promoter of the SERPINE1 gene)
MVZ Labor Dr. Reising-Ackermann und Kollegen
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Mecklenburg-Vorpommern
ROSTOCK

Accreditation
Risk calculation on molecular basis for thrombophilia (F2 gene: G20210A mutation)
Diagenom GmbH
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Hamburg
HAMBURG

Accreditation
Molecular diagnosis of factor V Leiden mutation
GenteQ GmbH
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Hamburg
HAMBURG

Accreditation
Molecular diagnosis of MTHFR gene variant C677T
GenteQ GmbH
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

FRANCE

NORD-PAS-DE-CALAIS
VALENCIENNES

Accreditation
Molecular diagnosis of thrombosis risks (F2 gene: G20210A mutation; F5 gene: Leiden mutation; MTHFR gene)
Centre Hospitalier de Valenciennes
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

GERMANY

Niedersachsen
GÖTTINGEN

Accreditation
Molecular diagnosis of factor V Leiden mutation
Institut für Humangenetik der Universität Göttingen
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : Sanger sequencing

GERMANY

Niedersachsen
GÖTTINGEN

Accreditation
Risk calculation on molecular basis for thrombophilia (F2 gene: G20210A mutation)
Institut für Humangenetik der Universität Göttingen
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : Sanger sequencing

GERMANY

Hamburg
HAMBURG

Accreditation
Molecular diagnosis of factor V deficiency and resistance to activated protein C
Labor Lademannbogen
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Hamburg
HAMBURG

Accreditation
Risk calculation on molecular basis for thrombophilia (F2 gene: G20210A mutation, PROZ, SERPINA10 gene)
Labor Lademannbogen
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region
Technical procedure(s) : Sanger sequencing

GERMANY

Hamburg
HAMBURG

Accreditation
Molecular diagnosis of MTHFR gene variant C677T
Labor Lademannbogen
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GREECE

ATTIKI
ATHENS

Accreditation
Molecular diagnosis of resistance to activated protein C (F5 gene: R506Q mutation)
BioAnalytica-GenoType SA
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GREECE

ATTIKI
ATHENS

Accreditation
Molecular diagnosis of hyperprothrombinemia (F2 gene: G20210A mutation)
BioAnalytica-GenoType SA
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GREECE

ATTIKI
ATHENS

Accreditation
Molecular diagnosis of MTHFR deficiency (C677T and A1298C mutations)
BioAnalytica-GenoType SA
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Bayern
MÜNCHEN

Accreditation
Risk calculation on molecular basis for thrombophilia (F2 gene: G20210A mutation)
Medizinisch Genetisches Zentrum München
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : Sanger sequencing

UNITED KINGDOM

South Glamorgan
CARDIFF

Accreditation
Molecular diagnosis of MTHFR deficiency due to C667T thermolabile variant
University Hospital of Wales
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Hamburg
HAMBURG

Accreditation
Risk calculation on molecular basis for thrombophilia (F2 gene: G20210A mutation)
GenteQ GmbH
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

BELGIUM

VLAAMS BRABANT
LEUVEN

Accreditation
Molecular diagnosis of Non rare thrombophilia (R506Q - Factor V Leiden)
University Hospitals Leuven - Gasthuisberg
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

BELGIUM

VLAAMS BRABANT
LEUVEN

Accreditation
Molecular diagnosis of Non rare thrombophilia (Factor II 20210G>A variant)
University Hospitals Leuven - Gasthuisberg
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

BELGIUM

VLAAMS BRABANT
LEUVEN

Accreditation
Molecular diagnosis of Non rare thrombophilia (MTHFR C677T variant)
University Hospitals Leuven - Gasthuisberg
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

FRANCE

PROVENCE-ALPES-COTE D'AZUR
NICE

Accreditation
Molecular diagnosis of non rare thrombophilia (F5 gene: Leiden mutation; F2 gene: G20210A mutation)
CHU de Nice - Hôpital Pasteur
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

SWITZERLAND

Suisse Italienne
LUGANO

Accreditation
Molecular diagnosis of resistance to activated protein C
Procrea Lab SA - Laboratorio di Genetica Molecolare
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

SWITZERLAND

Suisse Italienne
LUGANO

Accreditation
Molecular diagnosis of Congenital factor II deficiency
Procrea Lab SA - Laboratorio di Genetica Molecolare
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

ESTONIA

Tartu
TARTU

Accreditation
Molecular diagnosis of non rare thrombophilia (F5 gene: Leiden mutation, F2 gene: G20210A variant, MTHFR gene: C667T and A1298C variants)
Asper Biotech Ltd.
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

UNITED KINGDOM

Cambridgeshire
CAMBRIDGE

Accreditation
Molecular diagnosis of thrombophilia: factor V Leiden (F5 gene: R534Q (p.R506Q) mutation) and factor II (F2 gene G20210A mutation)
Addenbrooke's Hospital
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

SWITZERLAND

Suisse Alémanique
ZÜRICH

Accreditation
Molecular diagnosis of factor V deficiency and resistance to activaded protein C (F5 gene)
Genetica AG
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

FRANCE

ILE-DE-FRANCE
IVRY SUR SEINE

Accreditation
Molecular diagnosis of non rare thrombophilia (F2, F5, MTHFR genes)
Biomnis
Purpose(s) : Post-natal diagnosis, Pre-symptomatic diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

GERMANY

Nordrhein-Westfalen
KÖLN

Accreditation
Molecular diagnosis of non rare thrombophilia (FII, FV, MTHFR genes)
Praxisgemeinschaft für Laboratoriumsmedizin und Humangenetik
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technical procedure(s) : Sanger sequencing

GERMANY

Sachsen
DRESDEN

Accreditation
Molecular diagnosis of thrombophilia (4G/5G polymorphism in the promoter of the PAI1 gene)
Mitteldeutscher Praxisverbund Humangenetik
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

AUSTRIA

STEIERMARK
GRAZ

Accreditation
Molecular diagnosis of non-rare thrombophilia (factor V-Leiden mutation)
Medizinische Universität Graz
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

FRANCE

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

Accreditation
Molecular diagnosis of non rare thrombophilia (MTHFR gene)
CHU de Marseille - Hôpital de la Timone
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

GERMANY

Bayern
MÜNCHEN

Accreditation
Risk calculation on molecular basis for thrombophilia (F2 gene: G20210A mutation)
Medizinisches Versorgungszentrum Humane Genetik
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

AUSTRIA

TIROL
INNSBRUCK

Accreditation
Molecular diagnosis of hereditary thrombophilia (F2 gene)
Medizinische Universität Innsbruck
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

UNITED KINGDOM

Lanarkshire
GLASGOW

Accreditation
Molecular diagnosis of non rare thrombophilia (F5 gene: G1691A mutation)
Southern General Hospital
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

FRANCE

ILE-DE-FRANCE
PARIS

Accreditation
Molecular diagnosis of non rare thrombophilia (MTHFR gene)
CHU Paris IdF Ouest - HEGP Hôpital Européen Georges Pompidou
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

CANADA

Ontario
MISSISSAUGA

Accreditation
Molecular diagnosis of non-rare Thrombophilia (by F2, FV Allele-specific PCR)
Trillium Health Partners- Credit Valley Site
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Technical procedure(s) : PCR based techniques

SWITZERLAND

Suisse Romande
GENÈVE

Accreditation
Molecular diagnosis of non rare thrombophilia: factor II (gene F2 mutation G20210A)
Hôpitaux Universitaires de Genève HUG
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

SWITZERLAND

Suisse Romande
GENÈVE

Accreditation
Molecualr diagnosis of non rare thrombophilia (F5 gene: Leiden (R506Q) mutation detection)
Hôpitaux Universitaires de Genève HUG
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

SWITZERLAND

Suisse Romande
LAUSANNE

Accreditation
Molecular diagnosis of non rare thrombophilia (F2 gene, F5 gene)
Synlab Lausanne
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Bayern
MÜNCHEN

Accreditation
Molecular diagnosis of thrombophilia (4G/5G polymorphism in the promoter of the PAI1 gene)
Medizinisches Versorgungszentrum Humane Genetik
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

CANADA

Ontario
OTTAWA

Accreditation
Molecular Diagnosis of Non-Rare Thrombophilia (F2, FV targeted mutation analysis)
Children's Hospital of Eastern Ontario
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

CANADA

Ontario
TORONTO

Accreditation
Molecular Diagnosis of Familial Thrombosis (FVL, F2 targeted mutation analysis)
North York General Hospital
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis

CANADA

Ontario
TORONTO

Accreditation
Molecular Diagnosis of Predisposition to Thrombophilia (FVL, F2 g.20210G>A, MTHFR c.677 C>T)
Mount Sinai Hospital
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

GERMANY

Bayern
MÜNCHEN

Accreditation
Risk calculation on molecular basis for thrombophilia (F2 gene: G20210A mutation)
Pränatalmedizin München
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Bayern
MÜNCHEN

Accreditation
Molecular diagnosis of MTHFR deficiency (MTHFR gene)
Pränatalmedizin München
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technical procedure(s) : Sanger sequencing, MLPA based techniques

GERMANY

Baden-Württemberg
TÜBINGEN

Accreditation
Molecular diagnosis of non rare thrombophilia (F2, F5, F12 genes: sequencing)
CeGaT GmbH
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technical procedure(s) : Sanger sequencing

FRANCE

RHONE-ALPES
LYON

Accreditation
Diagnosis of non rare thrombophilia (F5 gene)
Biomnis
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

FRANCE

ILE-DE-FRANCE
SURESNES

Accreditation
Diagnosis of non rare thrombophilia (F2, F5 genes)
Hopital Foch
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technical procedure(s) : PCR based techniques

UNITED KINGDOM

Devon
EXETER

Accreditation
Molecular diagnosis of Congenital Factor V Deficiency (Leiden)
Royal Devon and Exeter Hospital - Wonford site
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

UNITED KINGDOM

Devon
EXETER

Accreditation
Molecular diagnosis of hyperprothrombinemia (Prothrombin 20210A mutation)
Royal Devon and Exeter Hospital - Wonford site
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

UNITED KINGDOM

Greater Manchester
MANCHESTER

Accreditation
Molecular diagnosis of thrombophilia by genotyping (Factor V Leiden and Prothrombin G20210A)
Central Manchester University Hospitals - Manchester Royal Infirmary
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Baden-Württemberg
SINGEN /HTWL.

Accreditation
Molecular diagnosis of factor V Leiden mutation
Institut für Laboratoriumsmedizin und Humangenetik
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Baden-Württemberg
SINGEN /HTWL.

Accreditation
Risk calculation on molecular basis for thrombophilia (F2 gene: G20210A mutation)
Institut für Laboratoriumsmedizin und Humangenetik
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Baden-Württemberg
SINGEN /HTWL.

Accreditation
Molecular diagnosis of MTHFR gene variant C677T
Institut für Laboratoriumsmedizin und Humangenetik
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Nordrhein-Westfalen
BAD OEYNHAUSEN

Accreditation
Molecular diagnosis of MTHFR gene variant C677T
Ruhr-Universität Bochum
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Nordrhein-Westfalen
BAD OEYNHAUSEN

Accreditation
Molecular diagnosis of factor V Leiden mutation
Ruhr-Universität Bochum
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

UNITED KINGDOM

Devon
PLYMOUTH

Accreditation
Molecular diagnosis of hyperprothrombinemia (Prothrombin 20210A mutation)
Plymouth Derriford Hospital
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

UNITED KINGDOM

Devon
PLYMOUTH

Accreditation
Molecular diagnosis of Congenital Factor V Deficiency (Leiden, F5 gene G617A mutation)
Plymouth Derriford Hospital
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

CZECH REPUBLIC

Plzen
KLATOVY

Accreditation
Molecular diagnosis of non rare thrombophilia (G20210A variant of the F2 gene)
BioLab spol. s.r.o.
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Bayern
BAD STEBEN

Accreditation
Molecular diagnosis of factor V Leiden mutation
Institut für angewandte Humangenetik und Onkogenetik
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

AUSTRIA

WIEN
WIEN

Accreditation
Molecular diagnosis of non rare thrombophilia (MTHFR gene variant C677T, F2 gene, F5 gene)
Medizinische Universität Wien
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Baden-Württemberg
HEIDELBERG

Accreditation
Molecular diagnosis of factor V Leiden mutation
Zentrallabor des Universitätsklinikums Heidelberg
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Baden-Württemberg
HEIDELBERG

Accreditation
Risk calculation on molecular basis for thrombophilia (F2 gene: G20210A mutation)
Zentrallabor des Universitätsklinikums Heidelberg
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

SWITZERLAND

Suisse Romande
GENÈVE

Accreditation
Molecular diagnosis of Factor V Deficiency (Leiden)
Hôpitaux Universitaires de Genève HUG
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

FRANCE

BRETAGNE
LORIENT

Accreditation
Molecular diagnosis of resistance to activated protein C (F5 gene)
BIOLOR
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

CZECH REPUBLIC

South Bohemia
CESKE BUDEJOVICE

Accreditation
Molecular diagnosis of non rare thrombophilia (MTHFR, F5 and F2 genes)
Centrum lekarske genetiky s.r.o.
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

CZECH REPUBLIC

South Moravia
BRNO

Accreditation
Molecular diagnosis of non rare thrombophilia (F2, F5 and CFTR genes)
Cytogenetic laboratory Brno,s.r.o.
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

FRANCE

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

Accreditation
Molecular diagnosis of thrombosis risks (F5, F2 genes)
CHU de Marseille - Hôpital de la Timone
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

FRANCE

ILE-DE-FRANCE
PARIS

Accreditation
Molecular diagnosis of thrombosis risks (F2, F5 genes)
CHU Paris Est - Hôpital d'Enfants Armand-Trousseau
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technical procedure(s) : PCR based techniques

CZECH REPUBLIC

Plzen
PLZEN

Accreditation
Molecular diagnosis of non rare thrombophilia (MTHFR, F2 and F5 genes)
Genetika Plzen
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

CZECH REPUBLIC

South Moravia
HODONIN

Accreditation
Molecular diagnosis of non rare thrombophilia (MTHFR, F2 and F5 genes)
Chemila, spol. s r.o.
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Baden-Württemberg
STUTTGART

Accreditation
Molecular diagnosis of thrombophilia (marker FV, FII, MTHFR, 4G/5G polymorphism in the promoter of the PAI1 gene)
Labor Prof. Dr. G. Enders MVZ
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

UNITED KINGDOM

Nottinghamshire
NOTTINGHAM

Accreditation
Molecular diagnosis of thrombophilia risk factors (multiplex analysis of the prothrombin 20210G>A and F5 c.1601G>A variants)
Queen's Medical Centre
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

FRANCE

CENTRE
CHAMBRAY-LES-TOURS

Accreditation
Molecular diagnosis of non rare thrombophilia (F2, F5 genes)
SELAS Arnaud-Biolys-Origet
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

FRANCE

MIDI-PYRENEES
TOULOUSE

Accreditation
Molecular diagnosis of non rare thrombophilia (F2 and F5 genes)
CHU de Toulouse - Hôpital Purpan
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

CANADA

Ontario
KINGSTON

Accreditation
Molecular Diagnosis of Familial Thrombosis (FVL, prothrombin, MTHFR targeted mutation analysis)
Kingston General Hospital
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis

CANADA

Ontario
TORONTO

Accreditation
Molecular Diagnosis of Inherited Predisposition to Thrombophilia (Factor V Leiden, FII G20210A, MTHFR C677T)
Toronto General Hospital
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

CANADA

Terre-Neuve-et-Labrador
ST. JOHN'S

Accreditation
Molecular Diagnosis of Predisposition to Thrombophilia (FVL, F2 c.*97G>A)
Health Sciences Centre
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

FRANCE

ILE-DE-FRANCE
PARIS

'Molecular diagnosis of non rare thrombophilia (F5 gene: mutation G1691A; F2 gene: G20210A mutation; MTHFR gene: C677T mutation)'
CHU Paris Nord-Val de Seine - Hôpital Xavier Bichat-Claude Bernard
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region
Technical procedure(s) : Sanger sequencing, PCR based techniques

GERMANY

Nordrhein-Westfalen
ESSEN

Molecular diagnosis of thrombophilia (4G/5G polymorphism in the promoter of the SERPINE1 gene)
Laborärztlich-humangenetische Partnerschaft Eiben - Glaubitz
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

FRANCE

ILE-DE-FRANCE
BOBIGNY

Molecular diagnosis of non rare thrombophilia (MTHFR, F2 and F5 genes)
CHU Paris Seine-Saint-Denis - Hôpital Avicenne
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

GERMANY

Berlin
BERLIN

Molecular diagnosis of thrombophilia (marker FV, FII, MTHFR, 4G/5G polymorphism in the promoter of the PAI1 gene)
Berlin-Potsdam MVZ GbR
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

SPAIN

Aragón
ZARAGOZA

Molecular diagnosis of non rare thrombophilia (Leiden mutation in F5 gene, G20210A variant in F2 gene and C677T in MTHFR gene)
Hospital Universitario Miguel Servet
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

PORTUGAL

SUL
LISBOA

Analysis of thrombosis predisposition genetic factors (MTHFR C667T and A1298C, PAI-1 -675G>A; F5: 1691 G>A; F2: 20210 G>A)
Instituto Nacional de Saúde Dr. Ricardo Jorge - Lisboa
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

ESTONIA

Tartu
TARTU

Molecular diagnosis of hyperprothrombinemia (Prothrombin G20210A mutation)
Tartu University Hospital
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

ESTONIA

Tartu
TARTU

Molecular diagnosis of factor V Leiden
Tartu University Hospital
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

PORTUGAL

NORTE
PORTO

Molecular diagnosis of congenital factor II deficiency (F2 gene: Target mutation analysis - single mutation, G20210A mutation)
CGC Genetics / Centro de Genética Clínica
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis

FRANCE

LORRAINE
EPINAL

Molecular genetics diagnosis ofnon rare thrombophilia (F2, F5 genes)
Analysis - Laboratoire Lefaure & Petit
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

GERMANY

Niedersachsen
OSNABRÜCK

Molecular diagnosis of factor V Leiden mutation
Praxis Dres. Gencik
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Niedersachsen
OSNABRÜCK

Molecular diagnosis of MTHFR gene variant C677T
Praxis Dres. Gencik
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Niedersachsen
OSNABRÜCK

Molecular diagnosis of thrombophilia (4G/5G polymorphism in the promoter of the SERPINE1 gene)
Praxis Dres. Gencik
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

NORWAY

Vestlandet
BERGEN

Molecular diagnosis of factor V Leiden (F5 gene)
Haukeland University Hospital
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Berlin
BERLIN

Molecular diagnosis of factor V Leiden mutation
Praxis für medizinische Genetik
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Bayern
ERLANGEN

Molecular diagnosis of factor V Leiden mutation
Humangenetisches Institut am Universitätsklinikum Erlangen
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Bayern
REGENSBURG

Molecular diagnosis of factor V Leiden mutation
Gemeinschaftspraxis Dr. Susanne Ebner und Dr. Susanne Markus
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Niedersachsen
HILDESHEIM

Molecular diagnosis of factor V Leiden mutation
Gemeinschaftspraxis Dres. Algermissen / Justus / Wilke / Graf
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Nordrhein-Westfalen
ESSEN

Molecular diagnosis of factor V Leiden mutation
Laborärztlich-humangenetische Partnerschaft Eiben - Glaubitz
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

TURKEY

TURKEY
ISTANBUL

Molecular diagnosis of factor V Leiden
BURC Genetics Diagnostic Center
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

SPAIN

Comunidad Valenciana
VALENCIA

Diagnosis of non rare thrombophilia (F2, F5 genes)
Hospital Universitario y Politécnico La Fe
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technical procedure(s) : PCR based techniques

GERMANY

Nordrhein-Westfalen
MÜNSTER

Risk calculation on molecular basis for thrombophilia (F2 gene: G20210A mutation)
Institut für Humangenetik des Universitätsklinikums Münster
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Nordrhein-Westfalen
MÜNSTER

Molecular diagnosis of factor V Leiden mutation
Institut für Humangenetik des Universitätsklinikums Münster
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Bayern
REGENSBURG

Risk calculation on molecular basis for thrombophilia (F2 gene: G20210A mutation)
Gemeinschaftspraxis Dr. Susanne Ebner und Dr. Susanne Markus
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

ITALY

VENETO
COSTOZZA DI LONGARE

Molecular diagnosis of thrombophilia (F5 gene)
B.I.R.D. Foundation
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

SWITZERLAND

Suisse Alémanique
REINACH

Molecular diagnosis of factor V deficiency and resistance to activated protein C (Leiden, R506Q mutation)
Diagene Laboratories Inc.
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

SWITZERLAND

Suisse Alémanique
REINACH

Molecular diagnosis of Homocystinuria due to Methylene Tetrahydrofolate Reductase deficiency (MTHFR gene: C677T mutation)
Diagene Laboratories Inc.
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Hessen
FRANKFURT AM MAIN

Molecular diagnosis of MTHFR gene variant C677T
bio.logis Zentrum für Humangenetik
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Hessen
FRANKFURT AM MAIN

Molecular diagnosis of factor V Leiden mutation
bio.logis Zentrum für Humangenetik
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

ITALY

LAZIO
ROMA

Molecular diagnosis of factor V Leiden mutation
Policlinico Umberto I
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Hamburg
HAMBURG

Molecular diagnosis of factor V Leiden mutation
Pränatalzentrum Hamburg und Humangenetik
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Hamburg
HAMBURG

Risk calculation on molecular basis for thrombophilia (F2 gene: G20210A mutation)
Pränatalzentrum Hamburg und Humangenetik
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Hamburg
HAMBURG

Molecular diagnosis of MTHFR gene variant C677T
Pränatalzentrum Hamburg und Humangenetik
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Bayern
NÜRNBERG

Risk calculation on molecular basis for thrombophilia (F2 gene: G20210A mutation)
Medizinisches Versorgungszentrum
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Bayern
NÜRNBERG

Molecular diagnosis of factor V Leiden mutation
Medizinisches Versorgungszentrum
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Bayern
NÜRNBERG

Molecular diagnosis of MTHFR gene variants C677T and A1298C
Medizinisches Versorgungszentrum
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Bayern
NÜRNBERG

Molecular diagnosis of thrombophilia (4G/5G polymorphism in the promoter of the SERPINE1 gene)
Medizinisches Versorgungszentrum
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

SPAIN

Andalucía
MÁLAGA

Molecular diagnosis of resistance to activated protein C. F5 gene.
Genetaq
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

FRANCE

ILE-DE-FRANCE
SAINT-MANDÉ

Molecular diagnosis of non rare thrombophilia (F2 (G20210A mutation), F5 (Leiden mutation) genes)
Hôpital d'Instruction des Armées Bégin
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

Molecular diagnosis of Non rare thrombophilia (Factor V Leiden - R506Q)
Universitair Ziekenhuis Brussel - UZBrussel
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

Molecular test for predisposition to thrombophilia (F2 gene - 20210G>A)
Universitair Ziekenhuis Brussel - UZBrussel
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

PORTUGAL

NORTE
PORTO

Molecular diagnosis of predisposition to thrombophilia (F5 gene: targeted mutation analysis - single mutation (R506Q))
CGC Genetics / Centro de Genética Clínica
Purpose(s) : Post-natal diagnosis, Somatic genetics, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis

FRANCE

PAYS DE LA LOIRE
LE MANS

Molecular diagnosis of thrombophilia (F5 gene: Leiden mutation; F2 gene: G20210A mutation; MTHFR gene)
Centre Hospitalier du Mans
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

FRANCE

FRANCHE-COMTE
BESANÇON

Molecular diagnosis of non rare thrombophilia (F5 and F2 genes)
EFS - Bourgogne/Franche-Comté
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

FRANCE

BRETAGNE
BREST

Molecular diagnosis of risk factors for thrombosis (F5 and F2 genes)
CHRU de Brest - Hôpital Morvan
Purpose(s) : Post-natal diagnosis, Pre-symptomatic diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

POLAND

Warszawa
WARSAW

FRANCE

BOURGOGNE
DIJON

Molecular diagnosis of non rare thrombophilia (F5, F2 MTHFR genes)
CHU de Dijon - Plateau technique de Biologie
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

FRANCE

POITOU-CHARENTES
POITIERS

Molecular diagnosis of non rare thrombophilia (F2, F5 genes)
CHU de Poitiers
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

FRANCE

RHONE-ALPES
SAINT-PRIEST-EN-JAREZ

Molecular diagnosis of non rare thrombophilia (F5 and F2 genes)
CHU de Saint-Etienne - Hôpital Nord
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

POLAND

Poznan
POZNAN

Molecular diagnosis of risk factors for thrombophilia (Leiden mutation in F5 gene; G20210A variant in F2 gene; C677T in MTHFR gene - RFLP analysis)
Centrum Genetyki Medycznej GENESIS
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Baden-Württemberg
HEIDELBERG

Molecular diagnosis of resistance to activated protein C (factor V Leiden, factor V Cambridge)
Molekulargenetisches Labor der Gemeinschaftspraxis
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Baden-Württemberg
HEIDELBERG

Risk calculation on molecular basis for thrombophilia (F2 gene: G20210A mutation)
Molekulargenetisches Labor der Gemeinschaftspraxis
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Baden-Württemberg
HEIDELBERG

Molecular diagnosis of MTHFR gene variant C677T
Molekulargenetisches Labor der Gemeinschaftspraxis
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Baden-Württemberg
HEIDELBERG

Molecular diagnosis of thrombophilia (4G/5G polymorphism in the promoter of the SERPINE1 gene)
Molekulargenetisches Labor der Gemeinschaftspraxis
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

ITALY

LOMBARDIA
BUSTO ARSIZIO

Molecular diagnosis of thrombophilia risks (F5, F2 and MTHFR genes)
Toma Advanced Biomedical Assays S.p.A.
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

TURKEY

TURKEY
ANKARA

Molecular diagnosis of non rare thrombophilia (Leiden mutation in the F5 gene; G20210A mutation in the F2 gene; MTHFR C677T polymorphism)
Intergen Genetics Center
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

FRANCE

ALSACE
MULHOUSE

Molecular diagnosis of non rare thrombophilia (F5 and F2 genes)
CH de Mulhouse - Hôpital Emile Muller
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

FRANCE

ILE-DE-FRANCE
PARIS

Molecular diagnosis of non rare thrombophilia (F2 and F5 genes)
CHU Paris Est - Hôpital Saint-Antoine
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

FRANCE

AUVERGNE
CLERMONT-FERRAND

Molecular diagnosis of non rare thrombophilia (F2, F5 and MTHFR genes)
Faculté de médecine de Clermont-Ferrand
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

FRANCE

LANGUEDOC-ROUSSILLON
MONTPELLIER

Molecular diagnosis of non rare thrombophilia (F2 and F5 genes)
CHRU de Montpellier - Hôpital Saint-Eloi
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

FRANCE

ALSACE
STRASBOURG

Molecular diagnosis of non rare thrombophilia (F5, F2 and MTHFR genes)
CHU de Strasbourg - Hôpital de Hautepierre
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

FRANCE

LORRAINE
METZ

Molecular diagnosis of thrombophilia: factor V Leiden (gene F5 mutation G1691A) and factor II (gene F2 mutation G20210A)
CHR de Metz-Thionville
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

SPAIN

Andalucía
ARMILLA

ITALY

EMILIA ROMAGNA
PARMA

Molecular diagnosis of non rare trombophilia (F2, F5, MTHFR genes)
Azienda Ospedaliera Universitaria di Parma
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

SPAIN

Comunidad Valenciana
PATERNA

Molecular diagnosis of non rare thrombophilia (F2, F5 and MTHFR genes)
Sistemas Genómicos S.L.
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

ITALY

LOMBARDIA
SAN FERMO DELLA BATTAGLIA

Molecular diagnosis of thrombophilia risks (F2, F5, MTHFR)
ASST Lariana - Ospedale S.Anna di Como
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

ITALY

SICILIA
CATANIA

Molecular diagnosis of thrombophilia (F2, F5, MTHFR genes)
CPSS - Centro Polidiagnostico Servizi Sanitari
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

SPAIN

Comunidad Valenciana
PATERNA

Molecular diagnosis of susceptibility to non rare thrombophilia (F2, F5 and MTHFR genes)
IMEGEN - Instituto de Medicina Genómica
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

GERMANY

Baden-Württemberg
ULM

Molecular diagnosis of non rare thrombophilia (MTHFR gene variant C677T)
MVZ Humangenetik Ulm
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

ITALY

TOSCANA
PISA

Postnatal molecular diagnosis of thrombophilia (F2, F5, MTHFR genes)
Azienda Ospedaliero Universitaria Pisana - Ospedale S. Chiara
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technical procedure(s) : NGS sequencing (except WES), Sanger sequencing

GERMANY

Bayern
REGENSBURG

Molecular diagnosis of non rare thrombophilia (gene variant C677T)
Gemeinschaftspraxis Dr. Susanne Ebner und Dr. Susanne Markus
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

FRANCE

LORRAINE
VANDOEUVRE-LÈS-NANCY

Molecular diagnosis of non rare thrombophilia (F5 gene : Leiden mutations ; F2 gene : G20210A mutation)
CHU de Nancy - Hôpital de Brabois
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

GERMANY

Sachsen
DRESDEN

Molecular diagnosis of thrombophilia (F2 gene: G20210A mutation)
Gemeinschaftspraxis für Humangenetik
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Sachsen
DRESDEN

Molecular diagnosis of factor V Leiden mutation
Gemeinschaftspraxis für Humangenetik
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Sachsen
DRESDEN

Molecular diagnosis of MTHFR gene variants C677T and A1298C
Gemeinschaftspraxis für Humangenetik
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

ITALY

LAZIO
ROMA

Molecular diagnosis of non rare thrombophilia (F2, F5, MTHFR genes)
Azienda Ospedaliera S. Camillo-Forlanini - Ospedale San Camillo
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

ITALY

TOSCANA
PRATO

Molecular diagnosis of non rare thrombophilia (F2, F5 genes)
USL4 - Nuovo Ospedale Santo Stefano
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

FRANCE

AQUITAINE
BORDEAUX

Molecular diagnosis of non rare thrombophilia (MTHFR gene)
CHU de Bordeaux-GH Pellegrin
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

CANADA

Québec
MONTRÉAL

Molecular diagnosis of Factor V Leiden thrombophillia (F5 gene: G1691A mutation by real-time PCR)
Centre hospitalier universitaire Sainte-Justine
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Technical procedure(s) : PCR based techniques

CANADA

Québec
MONTRÉAL

Molecular diagnosis of prothrombine-related thrombophilia (mutation G20210A of F2 gene)
Centre hospitalier universitaire Sainte-Justine
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

SPAIN

Andalucía
MÁLAGA

Molecular diagnosis of non rare thrombophilia (F5, F2, MTHFR genes)
Genetaq
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

SPAIN

La Rioja
LOGROÑO

Molecular diagnosis of non rare thrombophilia (MTHFR, F2, F5 genes)
CIBIR - Centro de Investigación Biomédica de La Rioja
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

CANADA

Québec
MONTRÉAL

Molecular diagnosis of non rare thrombophilia (MTHFR gene: C677T mutation)
Centre hospitalier universitaire Sainte-Justine
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

ITALY

LOMBARDIA
CUSANO MILANINO

Molecular diagnosis of thrombophilia risks (F5, F2 and MTHFR genes)
Istituto Auxologico Italiano
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

POLAND

Warszawa
WARSAW

SPAIN

Cataluña
TERRASSA

Molecular diagnosis of non rare thrombophilia (F2, F5, MTHFR genes)
Consorci Sanitari de Terrassa
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

PORTUGAL

CENTRO
OEIRAS

Molecular diagnosis of non rare thrombophilia (F5 gene mutation R506Q)
Laboratório de Análises Clínicas Dr. Joaquim Chaves
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

PORTUGAL

CENTRO
OEIRAS

Analysis of thrombosis predisposition genetic factors (MTHFR: C667T e A1298C; F5: FV Leiden; F2: G20210A)
Laboratório de Análises Clínicas Dr. Joaquim Chaves
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

SPAIN

Comunidad Valenciana
SANT JOAN D'ALACANT

Molecular diagnosis of non rare thrombophilia (F5 gene: mut. G1691A; F2 gene: mut. G20210A; MTHFR gene: mut. C677T, mut. A1298C)
Centro Inmunológico de Alicante (CIALAB)
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

PORTUGAL

ILHAS
FUNCHAL

Molecular diagnosis of non rare thrombophilia (F2 gene: Analysis of G20210A mutation by sequencing of the 3' region by qPCR)
Universidade da Madeira
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Technical procedure(s) : PCR based techniques

SPAIN

Comunidad Valenciana
ALICANTE

Molecular diagnosis of non rare thrombophilia (F5 gene / mutation G1691A; F2 gene / mutation G20210A)
Instituto Bernabeu Biotech
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

ITALY

SICILIA
AVOLA

Molecular diagnosis of non rare trombophilia (FII, FV, MTHFR genes)
Laboratori Campisi s.r.l.
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

ITALY

LAZIO
ROMA

Molecular diagnosis of non rare trombophilia (FII, FV, MTHFR genes)
Istituto CSS-Mendel
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

SPAIN

Asturias
OVIEDO

Molecular diagnosis of susceptibility to non rare thrombophilia (F2, F5, F12, MTHFR genes / PCR, region sequencing)
IMOMA - Instituto de Medicina Oncológica y Molecular de Asturias
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Technical procedure(s) : PCR based techniques

SPAIN

Cataluña
TARRAGONA

Molecular diagnosis of polycythemia vera (F2 gene / 20210A mutation detection; F5 gene / R506Q mutation detection; MTHFR gene / C677T and A1298C mutations detection)
Hospital Universitari de Tarragona Joan XXIII
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

ITALY

VENETO
LIMENA

Molecular diagnosis of non rare trombophilia (analysis of F2, F5, MTHFR genes determined by Real Time PCR)
RDI - RETE DIAGNOSTICA ITALIANA
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Technical procedure(s) : PCR based techniques

FRANCE

ILE-DE-FRANCE
BOULOGNE-BILLANCOURT

Molecular diagnosis of non rare thrombophilia (F2 and F5 genes)
CHU Paris IdF Ouest - Hôpital Ambroise Paré
Purpose(s) : Post-natal diagnosis, Pre-symptomatic diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

SPAIN

País Vasco
SAN SEBASTIÁN

Diagnosis of the susceptibility to non rare thrombophilia (F2, F5 and MTHFR genes)
DNA Data
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

POLAND

Gdansk
GDANSK

"Molecular diagnosis of non rare thrombophilia (Leiden mutation; G20210A mutation in F2 gene; MTHFR gene: C677T and A1298C)
INVICTA Sp. z o.o.
Purpose(s) : Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : NGS sequencing (except WES)

FRANCE

LANGUEDOC-ROUSSILLON
MONTPELLIER

Diagnosis of hemorrhagic disorders (Panel)
CHRU de Montpellier - Hôpital Saint-Eloi
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technical procedure(s) : NGS sequencing (except WES)

ITALY

LOMBARDIA
VARESE

Molecular diagnosis of non rare thrombophilia (F5 gene)
A.O.U. Ospedale di Circolo e Fondazione Macchi - Università dell'Insubria
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : NGS sequencing (except WES)

GERMANY

Baden-Württemberg
HEIDELBERG

Molecular diagnosis of thrombophilia (4G/5G polymorphism in the promoter of the PAI1 gene)
Zentrum für Kinder- und Jugendmedizin - Angelika-Lautenschläger-Klinik
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

FRANCE

ILE-DE-FRANCE
POISSY

Molecular diagnosis of non rare thrombophilia (MTHFR, F2 and F5 genes)
Centre hospitalier intercommunal Poissy-Saint-Germain-en-Laye
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

UNITED KINGDOM

Greater London
LONDON

Molecular diagnosis of Factor V Leiden mutation (G1691A mutation)
King's College Hospital
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

FRANCE

PAYS DE LA LOIRE
LE MANS

Phenotypic test of resistance to activated protein C
Centre Hospitalier du Mans
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Hematology

FRANCE

LORRAINE
VANDOEUVRE-LÈS-NANCY

Diagnosis of resistance to activated protein C
CHU de Nancy - Hôpital de Brabois
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Hematology

FRANCE

RHONE-ALPES
GRENOBLE

Molecular diagnosis of non rare thrombophilia (F5, F2, MTHFR genes)
CHU de Grenoble site Nord - Institut de biologie et de pathologie
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

FINLAND

Finland
TURKU

Molecular diagnosis of factor V Leiden
Turku University Hospital
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

SPAIN

Andalucía
GRANADA

Molecular Diagnosis of Hyperprothombinemia
Hospital Universitario Virgen de las Nieves
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

SPAIN

Navarra
PAMPLONA

Molecular diagnosis of Predisposition to thrombophilia. F5 gene
Complejo Hospitalario de Navarra - Hospital Virgen del Camino
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

GERMANY

Hessen
GIEßEN

Risk calculation on molecular basis for thrombophilia (F2 gene: G20210A mutation)
Humangenetische Praxis Dr. Schmidt & Mautner
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Hessen
GIEßEN

Molecular diagnosis of factor V Leiden mutation
Humangenetische Praxis Dr. Schmidt & Mautner
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Hessen
GIEßEN

Molecular diagnosis of MTHFR gene variants C677T and A1298C
Humangenetische Praxis Dr. Schmidt & Mautner
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

ITALY

LOMBARDIA
LODI

Molecular diagnosis of resistance to activated protein C (F5 gene)
Azienda Ospedaliera della Provincia di Lodi
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Hessen
FRANKFURT AM MAIN

Molecular diagnosis of factor V Leiden mutation
Praxis Dr. med. Ulrike Beudt
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Hessen
FRANKFURT AM MAIN

Molecular diagnosis of MTHFR gene variant C677T
Praxis Dr. med. Ulrike Beudt
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Hessen
FRANKFURT AM MAIN

Risk calculation on molecular basis for thrombophilia (F2 gene: G20210A mutation)
Praxis Dr. med. Ulrike Beudt
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

CZECH REPUBLIC

Moravia-Silesia
OSTRAVA

Molecular diagnosis of non rare thrombophilia (F5 and F2 genes)
CGB laboratory Ltd.
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

CZECH REPUBLIC

Usti nad Labem
USTI NAD LABEM

Molecular diagnosis of non rare thrombophilia (F2 gene: G20210A variant; F5 gene: Leiden mutation; MTHFR gene)
Masaryk hospital
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

SLOVENIA

SLOVENIA
LJUBLJANA

Molecular diagnosis of factor V Leiden thrombophilia (F5 gene)
University Medical Center Ljubljana
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

ITALY

PUGLIA
LECCE

Molecular diagnosis of resistance to activated protein C
Presidio Ospedaliero "Vito Fazzi" - ASL LE
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

HUNGARY

Közép-Magyarország
BUDAPEST

Molecular diagnosis of resistance to activated protein C by melting point analysis of F5 gene
Semmelweis University Hospital - 2nd Department of Paediatrics
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

DENMARK

Fyn
ODENSE

Molecular diagnosis of resistance to activated protein C (RFLP analysis of F5 gene)
Amplexa Genetics A/S
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

DENMARK

Fyn
ODENSE

Molecular diagnosis of factor II deficiency (RFLP analysis of F2 gene)
Amplexa Genetics A/S
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

ITALY

CALABRIA
REGGIO CALABRIA

Molecular diagnosis of resistance to activated protein C
Azienda Ospedaliera BMM
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

FRANCE

ILE-DE-FRANCE
ARGENTEUIL

Molecular diagnosis of non rare thrombophilia (F2 and F5 genes)
Centre hospitalier Victor Dupouy
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

CROATIA

CROATIA
ZAGREB

Molecular diagnosis of Factor V Deficiency (Leiden)
Zagreb Clinical Hospital Center
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

LATVIA

LATVIA
RIGA

Molecular diagnosis of Factor V Deficiency (Leiden)
BMC - Biomedical Research centre
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

SERBIA

Serbia
BELGRADE

Molecular diagnosis of Factor V Deficiency (Leiden)
Institute of Molecular Genetics and Genetic Engineering
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

ISRAEL

ISRAEL
HAIFA

Molecular diagnosis of Thrombophilia (APCR, MTHFR, Prothrombin, Mutation analysis)
The Bnai Zion Medical Center, Technion-Rappaport Faculty of Medicine
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Technical procedure(s) : PCR based techniques

ISRAEL

ISRAEL
JERUSALEM

Molecular diagnosis of Hypercoagulation (FV, Prothrombin, MTHFR, Mutation analysis)
Shaare Zedek Medical Center
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

ROMANIA

CLUJ
CLUJ-NAPOCA

Molecular diagnosis of MTHFR deficiency (C677T, A1298C and G1793A/T mutations)
Spitalul Judetean Clinc de Urgenta Cluj
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

ROMANIA

CLUJ
CLUJ-NAPOCA

Molecular diagnosis of hyperprothrombinemia (mutation G20210A of F2 gene)
Spitalul Judetean Clinc de Urgenta Cluj
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

ROMANIA

CLUJ
CLUJ-NAPOCA

Molecular diagnosis of resistance to activated protein C (F5 Leiden mutation)
Spitalul Judetean Clinc de Urgenta Cluj
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

POLAND

Lodz
LODZ

Molecular diagnosis of resistance to activated protein C (F5 gene : Leiden mutation)
Centralny Szpital Kliniczny Uniwersytetu Medycznego w Lodzi
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

SLOVENIA

SLOVENIA
LJUBLJANA

Molecular diagnosis of resistance to activated protein C (F5 gene: Leiden mutation)
University Medical Center Ljubljana
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

FRANCE

ILE-DE-FRANCE
PARIS

Molecular diagnosis of thrombophilia (F2, F5 and MTHFR genes)
Groupe Hospitalier Paris Saint-Joseph
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

GERMANY

Hessen
GIEßEN

Molecular diagnosis of thrombophilia (SERPINE1 gene: 4G/5G polymorphism, 844 A/G)
Humangenetische Praxis Dr. Schmidt & Mautner
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

CZECH REPUBLIC

Capital City Prague
PRAHA

Molecular diagnosis of factor V deficiency (F5 gene)
Sanatorium PRONATAL
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

CZECH REPUBLIC

Capital City Prague
PRAHA

Molecular diagnosis of non rare thrombophilia (F2 gene: G20210A mutation; F5 gene: Leiden mutation)
Sanatorium PRONATAL
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

FRANCE

BRETAGNE
QUIMPER

Molecular diagnosis of thrombosis risks (F5 gene: Leiden mutation; F2 and MTHFR genes)
CHI de Cornouaille
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

FRANCE

ALSACE
COLMAR

Molecular diagnosis of thrombosis risks (F5 gene : R506Q mutation; F2 gene: G20210A mutation)
Hôpital Pasteur - Hôpitaux civils de Colmar
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

FRANCE

PROVENCE-ALPES-COTE D'AZUR
TOULON

Molecular diagnosis of thrombosis risks (F5 and F2 genes)
CHI Toulon La Seyne-sur-Mer - Hôpital Sainte Musse
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons
Technical procedure(s) : PCR based techniques

CZECH REPUBLIC

Hradec Kralove
HRADEC KRALOVE

Molecular diagnosis of resistance to activated protein C (F5 gene: Leiden mutation)
Medical Genetics Laboratory
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

CZECH REPUBLIC

Hradec Kralove
HRADEC KRALOVE

Molecular diagnosis of hyperprothrombinemia (F2 gene: G20210A mutation)
Medical Genetics Laboratory
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

CZECH REPUBLIC

Hradec Kralove
HRADEC KRALOVE

Molecular diagnosis of MTHFR thermolabile variant: C677T mutation
Medical Genetics Laboratory
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GREECE

ATTIKI
ATHENS

Molecular diagnosis of resistance to activated protein C (F5 gene mutations)
Mitera General, Maternity and Children's Hospital
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

FRANCE

LANGUEDOC-ROUSSILLON
NÎMES

Molecular diagnosis of non rare thrombophilia (F2 (G20210A polymorphism), F5 (Leiden mutation), F12 (C46T polymorphism), PROCR (mutation A6936G) genes)
CHU de Nîmes - Hôpital Caremeau
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

FRANCE

CHAMPAGNE-ARDENNE
TROYES

Molecular diagnosis of resistance to activated protein C (F2, F5, MTHFR genes: Leiden mutation)
CH de Troyes - Hôpital des Hauts-Clos
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

FRANCE

CHAMPAGNE-ARDENNE
TROYES

Molecular diagnosis of hyperprothrombinemia (F2 gene)
CH de Troyes - Hôpital des Hauts-Clos
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

FRANCE

CHAMPAGNE-ARDENNE
TROYES

Molecular diagnosis of non rare thrombophilia (MTHFR gene variant)
CH de Troyes - Hôpital des Hauts-Clos
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

FRANCE

ILE-DE-FRANCE
GARCHES

Molecular diagnosis of thrombophilia (gène MTHFR ; F5 gene: Leiden mutation; F2 gene: G20210A mutation search by PCR)
CHU Paris IdF Ouest - Hôpital Raymond Poincaré
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Technical procedure(s) : PCR based techniques

FRANCE

ILE-DE-FRANCE
MONTFERMEIL

Molecular diagnosis of thrombophilia risk factors (F5 gene: Leiden mutation; F2 gene: G20210 mutation ; PCR analysis)
GHI Le Raincy-Montfermeil
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

FRANCE

CENTRE
MONTARGIS

Molecular diagnosis of thrombophilia risks (F5 gene: Leiden mutation; F2 gene: G20210A mutation; real-time PCR analysis)
MEDIBIO
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

FRANCE

ILE-DE-FRANCE
SAINT-DENIS

Molecular diagnosis of thrombophilia risk factors (F5 gene: Leiden mutation; F2 gene: G20210A mutation)
Centre Hospitalier de Saint-Denis
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

Molecular diagnosis of Predisposition to thrombophilia (specific F5 & F2 mutations)
Cliniques Universitaires UCL de Saint Luc - UCLStLuc
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

SLOVENIA

SLOVENIA
MARIBOR

Molecular diagnosis of non rare thrombophilia
Maribor general hospital
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

FRANCE

RHONE-ALPES
CHAMBERY

Molecular diagnosis of non rare thrombophilia (F2, F5 genes)
Hotel-Dieu
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

FRANCE

LIMOUSIN
LIMOGES

Molecular diagnosis of predisposition to thrombosis (F5, F2 and MTHFR genes)
CHU de Limoges - Hôpital Dupuytren
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : Sanger sequencing, PCR based techniques

FRANCE

ILE-DE-FRANCE
CORBEIL-ESSONNES

Molecular diagnosis of non rare thrombophilia (F5 gene: Leiden mutation; F2 gene; G20210A variant)
Centre Hospitalier Sud Francilien
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

POLAND

Kraków
KRAKOW

Molecular diagnosis of non rare thrombophilia (F2 gene: G20210A mutation; MTHFR gene: C677T variant)
Uniwersytecki Szpital Dzieciecy w Krakowie
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GREECE

IRAKLIO
HERAKLION

ITALY

LOMBARDIA
BRESCIA

Molecular diagnosis of thrombophilia (FII, FV and MTHFR genes)
Biodiversity
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

FRANCE

NORD-PAS-DE-CALAIS
LENS

Molecular diagnosis of non rare thrombophilia (F5 and F2 genes)
Centre hospitalier de Lens
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

FRANCE

ILE-DE-FRANCE
PARIS

Molecular diagnosis of non rare thrombophilia
CHU Paris - Hôpital Necker-Enfants Malades
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

CZECH REPUBLIC

Capital City Prague
PRAHA

Molecular diagnosis of non rare thrombophilia (F5 gene: Leiden mutation; F2: G20210A variant; MTHFR gene)
Gennet s.r.o.
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

FRANCE

AQUITAINE
BORDEAUX

Molecular diagnosis of non rare thrombophilia (F5, F2 genes)
CHU de Bordeaux-GH Pellegrin
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

FRANCE

RHONE-ALPES
LYON

Molecular diagnosis of non rare thrombophilia (F5, F2 and MTHFR genes)
CHU de Lyon HCL - GH Edouard Herriot
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

FRANCE

CENTRE
TOURS

Molecular diagnosis of non rare thrombophilia (F2 and F5 genes)
CHRU de Tours - Hôpital Trousseau
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

FRANCE

ILE-DE-FRANCE
PARIS

Molecular diagnosis of thrombosis risks (F2, F5 and MTHFR genes)
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Purpose(s) : Post-natal diagnosis, Pre-symptomatic diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

FRANCE

BASSE-NORMANDIE
CAEN

Molecular diagnosis of thrombosis risks (F5 and F2 genes)
CHU de Caen - Hôpital de la Côte de Nacre
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

FRANCE

ILE-DE-FRANCE
PARIS

Molecular diagnosis of thrombosis risks (F5 and F2 genes)
CHU Paris IdF Ouest - HEGP Hôpital Européen Georges Pompidou
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

ISRAEL

ISRAEL
TEL AVIV

Molecular diagnosis of non rare thrombophilia (F5, F2 and MTHFR genes)
Pronto Diagnostics Ltd.
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

ITALY

CALABRIA
MANGONE

Molecular diagnosis of risk factors for thrombophilia (F2, F5, MTHFR genes)
CNR
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

CZECH REPUBLIC

Capital City Prague
PRAHA

Molecular diagnosis of non rare thrombophilia (MTHFR, F2 and F5 genes)
IHBT - Institute of hematology and blood transfusion
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

CZECH REPUBLIC

Olomouc
OLOMOUC

Molecular diagnosis of non rare thrombophilia (F5, F2 and MTHFR genes)
University hospital Olomouc
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

FRANCE

ILE-DE-FRANCE
LE KREMLIN-BICÊTRE

Molecular diagnosis of non rare thrombophilia (F2 and F5 genes)
GHU Paris-Sud - Hôpital de Bicêtre
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

FRANCE

ILE-DE-FRANCE
PARIS

Molecular diagnosis of non rare thrombophilia (F2, F5 and MTHFR genes)
CHU Paris - Hôpital Robert Debré
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

FRANCE

ILE-DE-FRANCE
PARIS

Molecular diagnosis of non rare thrombophilia (F2 et F5 genes)
CHU Paris Centre - Hôpital Cochin
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

FRANCE

PICARDIE
AMIENS

Molecular diagnosis of non rare thrombophilia (F2, F5 genes and C677T , A1298C mutations in MTHFR gene)
CHU Amiens-Picardie - Site Sud
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

FRANCE

ILE-DE-FRANCE
PARIS

Molecular diagnosis of non rare thrombophilia (F5 (Leiden mutation and HR2 haplotype), F2 and MTHFR genes)
CHU Paris-GH St-Louis Lariboisière F.Widal - Hôpital Lariboisière
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

FRANCE

CHAMPAGNE-ARDENNE
REIMS

Molecular diagnosis of non rare thrombophilia (Leiden mutation in the F5 gene, MTHFR gene and G20210A variant in the F2 gene)
CHU de Reims - Hôpital Robert Debré
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

FRANCE

HAUTE-NORMANDIE
ROUEN

Molecular diagnosis of non rare thrombophilia (F5, F and MTHFR genes)
CHU de Rouen - Hôpital Charles Nicolle
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

FRANCE

ILE-DE-FRANCE
CRÉTEIL

Molecular diagnosis of non rare thrombophilia (F5 gene: Leiden mutation; F2 gene: G20210A variant)
CHU Henri Mondor
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

FRANCE

ILE-DE-FRANCE
PARIS

Diagnosis of susceptibility to non rare thrombophilia (F5 and F2 genes)
CHU Paris Est - Hôpital Tenon
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Uniparental disomy study, Deletion / Duplication analysis
Technical procedure(s) : PCR based techniques

CZECH REPUBLIC

South Bohemia
CESKE BUDEJOVICE

Molecular diagnosis of non rare thrombophilia (MTHFR, F2 and F5 genes)
Hospital Ceské Budejovice
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

CZECH REPUBLIC

Liberec
LIBEREC

Molecular diagnosis of non rare thrombophilia (MTHFR, F2 and F5 genes)
Regional Hospital Liberec, Krajska nemocnice Liberec
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

CZECH REPUBLIC

Plzen
PLZEN

Molecular diagnosis of non rare thrombophilia (MTHFR, F2 and F5 genes)
Genomia s.r.o.
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

CZECH REPUBLIC

Capital City Prague
PRAHA

Molecular diagnosis of non rare thrombophilia (MTHFR gene; F2 gene: G21210A variant; F5 gene: G1691A mutation)
GENvia Genetic Laboratory Ltd.
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

FRANCE

ILE-DE-FRANCE
AULNAY-SOUS-BOIS

Molecular diagnosis of non rare thrombophilia (F2 and F5 gene)
Centre Hospitalier Robert Ballanger
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

FRANCE

AQUITAINE
VILLENAVE D'ORNON

Molecular diagnosis of non rare thrombophilia (F2 and F5 Leiden genes)
Hôpital d'Instruction des Armées Robert PICQUE
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

SPAIN

La Rioja
LOGROÑO

Molecular diagnosis of non rare thrombophilia (F2, F5 and MTHFR genes)
Hospital San Pedro
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

ITALY

SICILIA
MESSINA

Molecular diagnosis of thrombophilia (F2, F5, MTHFR genes)
A.O.U. Policlinico "G. Martino"
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

ITALY

SARDEGNA
OZIERI

Molecular diagnosis of thrombophilia (F2, F5, MTHFR genes)
Presidio Ospedaliero di Ozieri - ASL 1
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

SPAIN

Madrid
MAJADAHONDA

Molecular diagnosis of non rare thrombophilia (F5 and MTHFR genes)
Genyca Innova
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

ITALY

LAZIO
ROMA

Molecular diagnosis of non rare thrombophilia (F2, F5, MTHFR genes)
USI - Unione Sanitaria Internazionale
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

CANADA

Québec
QUÉBEC

Molecular diagnosis of non rare thrombophilia (F5 gene / mutation G1691A)
CHUQ - Centre Hospitalier Universitaire de Québec - Hôtel-Dieu de Québec
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

CANADA

Québec
QUÉBEC

Molecular diagnosis of non rare thrombophilia (F2 gene / mutation G20210A)
CHUQ - Centre Hospitalier Universitaire de Québec - Hôtel-Dieu de Québec
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

AUSTRIA

WIEN
WIEN

Molecular diagnosis of factor V Leiden mutation
Medizinische Universität Wien
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

SPAIN

Andalucía
CÁDIZ

Molecular diagnosis of non rare thrombophilia (F5, F2, MTHFR genes)
Hospital Universitario Puerta del Mar
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

LATVIA

LATVIA
RIGA

Molecular diagnosis of non rare thrombophilia (F5, F2 and MTHFR gene: search for specific mutations)
Riga Stradins University
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

SLOVAKIA

Bratislavsky kraj
BRATISLAVA

Molecular diagnosis of hereditary thrombophilia (F5 gene: G1591A and H1299R; F2 gene: G20210A; MTHFR gene: C677T and A1298C; PROCR gene: A4600G and G4678C)
University Hospital Bratislava - Stare mesto
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

POLAND

Lodz
LODZ

Molecular diagnosis of non rare thrombophilia (F5 gene: Leiden mutation; F2 gene: G20210A variant; MTHFR gene: C677T and A1298C variants)
Centralny Szpital Kliniczny
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

FRANCE

BRETAGNE
RENNES

Molecular diagnosis of non rare thrombophilia (F2, F5 genes)
CHU de Rennes - Hôpital Pontchaillou
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

UNITED KINGDOM

Oxfordshire
OXFORD

Molecular diagnosis of Thrombophilia (F5, F2 genes)
John Radcliffe Hospital
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

ITALY

MOLISE
POZZILLI

Molecular diagnosis of non rare trombophilia (FII, FV, MTHFR genes)
Istituto Neurologico Mediterraneo - IRCCS Neuromed
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : Sanger sequencing, PCR based techniques

MOROCCO

Rabat
RABAT

Molecular diagnosis of factor V Leiden mutation
Institut National d'Hygiène
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

ITALY

BASILICATA
MATERA

Postnatal molecular diagnosis of non rare trombophilia (FV, FII, MTHFR genes)
Presidio Ospedaliero "Madonna delle Grazie" - Azienda Sanitaria di Matera (ASM)
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

FRANCE

PAYS DE LA LOIRE
NANTES

Molecular diagnosis of non rare thrombophilia (F2, F5 genes)
CHU de Nantes - Institut de Biologie
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

FRANCE

ILE-DE-FRANCE
GONESSE

Molecular diagnosis of non rare thrombophilia (F5 gene: mutation G1691A; F2 gene: G20210A mutation; MTHFR gene: C677T mutation)
Centre Hospitalier de Gonesse
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

SPAIN

Madrid
SAN SEBASTIÁN DE LOS REYES

Diagnosis of major susceptibility factor in non rare thrombophilia (F5 gene: mutation screening in G1691A; F2 gene: mutation screening in G20210A; MTHFR gene: mutation screening in C677T and A1298C; F12 gene/polymorphism screening in C46T)
Laboratorio de Genética Clínica, S.L.
Purpose(s) : Antenatal diagnosis, Post-natal diagnosis, Pre-symptomatic diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region
Technical procedure(s) : Sanger sequencing